A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, February 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 356 followers.

#newupdatesneuroonc #braintumours #neuroonc A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma - https://t.co/MhipIL1W1r

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.